Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Change in Acquisitions & Divestments (2021 - 2025)

Marimed (MRMD) has disclosed Change in Acquisitions & Divestments for 5 consecutive years, with $26000.0 as the latest value for Q1 2025.

  • On a quarterly basis, Change in Acquisitions & Divestments rose 100.0% to $26000.0 in Q1 2025 year-over-year; TTM through Sep 2025 was $63000.0, a 384.62% increase, with the full-year FY2024 number at $50000.0, changed N/A from a year prior.
  • Change in Acquisitions & Divestments was $26000.0 for Q1 2025 at Marimed, down from $37000.0 in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $70000.0 in Q4 2021 to a low of -$87000.0 in Q3 2023.
  • A 5-year average of $29000.0 and a median of $43000.0 in 2022 define the central range for Change in Acquisitions & Divestments.
  • Peak YoY movement for Change in Acquisitions & Divestments: crashed 252.63% in 2023, then skyrocketed 100.0% in 2025.
  • Marimed's Change in Acquisitions & Divestments stood at $70000.0 in 2021, then crashed by 38.57% to $43000.0 in 2022, then tumbled by 302.33% to -$87000.0 in 2023, then skyrocketed by 142.53% to $37000.0 in 2024, then decreased by 29.73% to $26000.0 in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Change in Acquisitions & Divestments are $26000.0 (Q1 2025), $37000.0 (Q4 2024), and $13000.0 (Q1 2024).